About NovaVision
NovaVision is a company based in Boca Raton (United States) founded in 2003. It operates as a HealthTech, and Subscription Services. NovaVision has raised $38 million across 3 funding rounds from investors including Johnson & Johnson Innovation – JJDC, Oakwood Medical and Tullis Health Investors. NovaVision has completed 1 acquisition, including Sight Science. NovaVision offers products and services including Vision Restoration Therapy (VRT) and NeuroEyeCoach. NovaVision operates in a competitive market with competitors including Newronika, Sight Science, EnClear Therapies, MindAffect and AccuMedical, among others.
- Headquarter Boca Raton, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Novavision Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$38 M (USD)
in 3 rounds
-
Latest Funding Round
$20 M (USD), Series C
Jan 09, 2007
-
Investors
Johnson & Johnson Innovation – JJDC
& 4 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NovaVision
NovaVision offers a comprehensive portfolio of products and services, including Vision Restoration Therapy (VRT) and NeuroEyeCoach. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Therapy is designed to restore vision post-injury.
Program is developed to improve eye movement efficiency.
Unlock access to complete
Unlock access to complete
Funding Insights of NovaVision
NovaVision has successfully raised a total of $38M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in January 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $20.0M
-
First Round
First Round
(30 Sep 2003)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2007 | Amount | Series C - NovaVision | Valuation |
investors |
|
| Feb, 2005 | Amount | Series B - NovaVision | Valuation |
investors |
|
| Sep, 2003 | Amount | Series A - NovaVision | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NovaVision
NovaVision has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Johnson & Johnson Innovation – JJDC, Oakwood Medical and Tullis Health Investors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm backed by Johnson & Johnson
|
Founded Year | Domain | Location | |
|
Growth stage VC fund investing in the US, Europe and Canada
|
Founded Year | Domain | Location | |
|
Healthcare investments are made by Tullis Health Investors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NovaVision
NovaVision has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Sight Science. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Visual rehabilitation for brain-injured patients with field loss is provided.
|
2006 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - NovaVision
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Novavision Comparisons
Competitors of NovaVision
NovaVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Newronika, Sight Science, EnClear Therapies, MindAffect and AccuMedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical devices for neurodegenerative diseases are developed.
|
|
| domain | founded_year | HQ Location |
Visual rehabilitation for brain-injured patients with field loss is provided.
|
|
| domain | founded_year | HQ Location |
Developer of device-based therapies to treat neurodegenerative disorders
|
|
| domain | founded_year | HQ Location |
Brain-computer interface headsets are developed for patient communication.
|
|
| domain | founded_year | HQ Location |
Neurovascular interventional devices for neurological disorders are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Novavision
Frequently Asked Questions about NovaVision
When was NovaVision founded?
NovaVision was founded in 2003.
Where is NovaVision located?
NovaVision is headquartered in Boca Raton, United States. It is registered at Boca Raton, Florida, United States.
Is NovaVision a funded company?
NovaVision is a funded company, having raised a total of $38M across 3 funding rounds to date. The company's 1st funding round was a Series A of $6M, raised on Sep 30, 2003.
What does NovaVision do?
NovaVision is engaged in providing therapies for vision loss caused by neurological conditions such as stroke or brain injury. Solutions are offered in the healthcare sector, specifically targeting vision rehabilitation. Two primary therapies, Vision Restoration Therapy (VRT) and NeuroEyeCoach, are developed to help patients recover and adapt to vision impairments. These evidence-based programs are supported by scientific research and clinical studies, aiming to improve patients quality of life through innovative treatment options.
Who are the top competitors of NovaVision?
NovaVision's top competitors include Newronika, Sight Science and Actipulse Neuroscience.
What products or services does NovaVision offer?
NovaVision offers Vision Restoration Therapy (VRT) and NeuroEyeCoach.
How many acquisitions has NovaVision made?
NovaVision has made 1 acquisition, including Sight Science.
Who are NovaVision's investors?
NovaVision has 5 investors. Key investors include Johnson & Johnson Innovation – JJDC, Oakwood Medical, Tullis Health Investors, Noro-Moseley Partners, and Crossbow Ventures.